Open AccessTislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life
Author(s) -
Eric Van Cutsem,
Kazuaki Kato,
Jaffer A. Ajani,
Lin Shen,
T. Xia,
Ningning Ding,
L. Zhan,
Gisoo Barnes,
S. B. Kim
Publication year - 2022
Publication title -
esmo open
Language(s) - English
Resource type - Journals
ISSN - 2059-7029
DOI - 10.1016/j.esmoop.2022.100517
Subject(s) - medicine , quality of life (healthcare) , docetaxel , oncology , randomized controlled trial , chemotherapy , physical therapy , visual analogue scale , performance status , nursing
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom